Siemens Healthineers AG (XTER:SHL) 3-Month Share Buyback Ratio : 0.00% (As of Mar. 2025 )

View and export this data going back to 2018. Start your Free Trial

What is Siemens Healthineers AG 3-Month Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Siemens Healthineers AG's current 3-Month Share Buyback Ratio was 0.00%.

Competitive Comparison of Siemens Healthineers AG's 3-Month Share Buyback Ratio

For the Medical Devices subindustry, Siemens Healthineers AG's 3-Month Share Buyback Ratio, along with its competitors' market caps and 3-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Siemens Healthineers AG's 3-Month Share Buyback Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's 3-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Siemens Healthineers AG's 3-Month Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Siemens Healthineers AG 3-Month Share Buyback Ratio Calculation

Siemens Healthineers AG's 3-Month Share Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

3-Month Share Buyback Ratio	=	(Shares Outstanding (EOP) (Dec. 2024 )	-	Shares Outstanding (EOP) (Mar. 2025 ))	/	Shares Outstanding (EOP) (Dec. 2024 )
	=	(1121.556	-	1121.556)	/	1121.556
	=	0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Siemens Healthineers AG (XTER:SHL) 3-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Siemens Healthineers AG 3-Month Share Buyback Ratio Related Terms

Siemens Healthineers AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (XTER:SHL) » Definitions » 3-Month Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

SEMHF:USA SMMNY:USA 1SHL:Italy SHLd:UK 0PMJ:UK SHL:Austria

Address

Siemensstrasse 3, Forchheim, BY, DEU, 91301

Website

https://www.siemens-healthineers.com

Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.

Executives

Darleen Caron	Board of Directors
Dr. Nathalie Von Siemens	Supervisory Board
Dr. Jochen Schmitz	Board of Directors
Prof. Dr. Ralf Peter Thomas	Supervisory Board
Dr. Christoph Zindel	Board of Directors
Dr. Andreas Christian Hoffmann	Supervisory Board
Peer M. Schatz	Supervisory Board
Dr. Bernhard Montag	Board of Directors

Siemens Healthineers AG Headlines

No Headlines